Primary prophylaxis in children with severe haemophilia A and B-Implementation over the last 20 years as illustrated in real-world data in the PedNet cohorts.

Ljung, Rolf; de Kovel, Marloes; van den Berg, H Marijke

Ljung, Rolf; de Kovel, Marloes; van den Berg, H Marijke.

Affiliation

Ljung R; Department of Clinical Sciences, Department of Paediatrics, Lund University, Lund, Sweden.
de Kovel M; PedNet Haemophilia Research Foundation, Baarn, the Netherlands.
van den Berg HM; PedNet Haemophilia Research Foundation, Baarn, the Netherlands.

Haemophilia ; 29(2): 498-504, 2023 Mar.

Article in En | MEDLINE | ID: mdl-36571801

Subject(s)

Hemophilia A; Hemophilia B; Child; Humans; Hemophilia A/complications; Hemophilia A/drug therapy; Hemophilia A/prevention & control; Factor VIII/therapeutic use; Hemorrhage/drug therapy; Hemarthrosis/prevention & control; Hemophilia B/drug therapy

Key words

factor IX deficiency prophylaxis; factor VIII deficiency; haemophilia A; haemophilia B; neutralizing antibodies

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Hemophilia B / Hemophilia A Type of study: Guideline / Risk_factors_studies Limits: Child / Humans Language: En Journal: Haemophilia Journal subject: HEMATOLOGIA Year: 2023 Type: Article Affiliation country: Sweden

Fulltext

XML

PubMed Links

Search on Google